IMM and consortium partners Protinhi Therapeutics and Artemis launched the preclinical development of pan-corona antiviral against COVID-19 and other corona viral threats
3 juli 2023
1.4M euros have been granted by ZonMw to the consortium to carry on the development of pan-corona antiviral initiated in the predecessor project PanCoroNed. The consortium is composed of a broad coalition of knowledge institutions and private stakeholders, including the Institute for Molecules and Materials (IMM) of Radboud University and